Bridgewater Advisors’s DexCom DXCM Stock Holding History

Bridgewater Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.08M	Buy	12,347 +26	+0.2%	+$1.73K	0.06%	146
2026 Q1	$721K	Sell	12,321 -39	-0.3%	-$2.72K	0.04%	184
2025 Q4	$890K	Sell	12,360 -10	-0.1%	-$647	0.06%	153
2025 Q3	$717K	Sell	12,370 -215	-2%	-$17K	0.05%	182
2025 Q2	$1.12M	Sell	12,585 -51	-0.4%	-$4K	0.09%	123
2025 Q1	$901K	Sell	12,636 -381	-3%	-$31.1K	0.08%	130
2024 Q4	$1.03M	Buy	13,017 +433	+3%	+$32.1K	0.11%	81
2024 Q3	$909K	Sell	12,584 -587	-4%	-$48.2K	0.1%	94
2024 Q2	$1.42M	Buy	+13,171	New	+$1.67M	0.18%	72
2014 Q2	$242K	Hold	24,432	–	–	0.2%	78
2014 Q1	$253K	Hold	24,432	–	–	0.25%	71
2013 Q4	$216K	Buy	+24,432	New	+$193K	0.22%	73

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Bridgewater Advisors's DXCM Position: Q2 2026 in Review

Bridgewater Advisors increased its DexCom (DXCM) stake by 0.21% in Q2 2026, buying an estimated $1.73K and bringing the position to 12,347 shares worth $1.08M. The position accounts for 0.06% of the portfolio, ranked #146.

Bridgewater Advisors first reported a position in DXCM in Q4 2013 and has held it in 12 quarters since. The position peaked at $1.42M in Q2 2024. 973 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Bridgewater Advisors held 12,347 shares of DexCom worth $1.08M as of Q2 2026.
Bridgewater Advisors bought 26 DexCom shares in Q2 2026, an estimated $1.73K.
DexCom made up 0.06% of Bridgewater Advisors's portfolio in Q2 2026, its #146 holding.
Bridgewater Advisors first reported a position in DexCom in Q4 2013 and has held it in 12 quarters since.
Bridgewater Advisors's DexCom position peaked at $1.42M in Q2 2024.
973 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Bridgewater Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.